Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;16(4):782-6.
doi: 10.1007/s12017-014-8327-5. Epub 2014 Oct 5.

Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population

Affiliations

Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population

Jingli Shan et al. Neuromolecular Med. 2014 Dec.

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant late-onset neuromuscular degenerative disease characterized by ptosis, dysphagia, and proximal muscle weakness. The genetic basis has been identified as an abnormal (GCN) expansion encoding the polyalanine tract in exon 1 of the polyadenylate-binding protein nuclear 1 gene (PABPN1). OPMD is worldwide distributed, but has rarely been reported in East Asians. In this study, we summarized the clinical and genetic characteristics of 34 individuals from 13 unrelated families in Chinese population. In our cohort, the mean age at onset was 47.2 years. Dysphagia, rather than ptosis, was the most common initial symptom. Genetically, we identified seven genotypes in our patients, including one compound heterozygote of (GCN)11/(GCN)12. The genetic heterogeneity implies that there is no single founder effect in Chinese population, and our data also support that the (GCN)11 polymorphism may have a disease-modifying effect. Additionally, the clinical features showed homogeneity within families, which suggests that other genetic factors apart from the already known genotype also play a role in modifying the phenotype.

PubMed Disclaimer

References

    1. Swiss Med Wkly. 2005 Oct 1;135(39-40):574-86 - PubMed
    1. J Neurol. 2012 Aug;259(8):1546-52 - PubMed
    1. Neurology. 1996 Mar;46(3):773-8 - PubMed
    1. J Neurol Sci. 2009 Mar 15;278(1-2):21-4 - PubMed
    1. Acta Neuropathol. 1980;49(1):85-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources